Navigation Links
Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results
Date:7/17/2008

--------------------

Renal

PD Therapy $73 $406 $479 $68 $375 $443

HD Therapy 24 95 119 27 83 110

--------------------------------------------------------------------------

Total Renal $97 $501 $598 $95 $458 $553

--------------------------------------------------------------------------

--------------------------------------------------------------------------

Baxter excluding

Transfusion Therapies $1,212 $1,935 $3,147 $1,162 $1,620 $2,782

--------------------------------------------------------------------------

--------------------------------------------------------------------------

Transfusion Therapies (3) $29 $13 $42 $34 $13 $47

--------------------------------------------------------------------------

--------------------------------------------------------------------------

TOTAL BAXTER $1,241 $1,948 $3,189 $1,196 $1,633 $2,829

==========================================================================

% Growth @ Actual Rates

-----------------------------

Interna-

US tional Total

--------------------------------------------------------------------------

BioScience

Recombinants 4% 30% 18%

Plasma Proteins 1% 32% 20%

Antibody Therapy 25% 53% 32%

Regenerative Medicine (1) 20% 32% 25%

Other (2) (25%) (14%) (15%)

-----
'/>"/>

SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related biology technology :

1. Bioniche Pharma Acquires Baxters ENLON(R) and ENLON-PLUS(R)
2. Baxters Board of Directors Declares Quarterly Dividend
3. Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
4. Baxters V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals
5. Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
6. Baxters Board of Directors Approves New Share Repurchase Authorization of $2 Billion
7. Baxter and Its Foundation Contribute Nearly $53 Million in 2007 to Address Critical Needs Locally and Globally
8. Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products
9. Baxter Declares Quarterly Dividend
10. Baxter Provides Update on Heparin Reactions
11. Baxters Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013 As the R&D sector ... within the industry to deliver better products, faster. ... pharma companies often means turning big ideas into ... in collaboration with Sensidose AB and Recipharm, is ... products to market sooner. The partnership resulted in ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. today ... of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody ... the HER2 oncoprotein," will be presented at the ... Clinical Oncology during the Developmental Therapeutics - Immunotherapy ... 4:15 – 4:30 PM.  The presentation will describe ...
(Date:5/21/2013)... Bed bugs have become so widespread in ... many turn to chemical-based pesticides for help to completely get ... risks those solutions present, the company advised the public to ... , According to My Cleaning Products, chemical-based pesticides are ... be. It shared that the pests have already developed immunity ...
(Date:5/21/2013)... May 21, 2013 Inflamax scientists ... the ITN to design the study, which will ... key clinical models used in the study of ... Nasal Allergen Challenge (NAC) models. Although both the ... publications, to date no direct comparison between the ...
Breaking Biology Technology:The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2
... , Strategic Examination and Consolidation ... WASHINGTON, Aug. 27 Little uniformity exists in the structure ... the future, according to Clinical Trials Offices: What,s New ... Academic Health Centers (AAHC). Emerging centralized clinical trial offices (CTOs) ...
... BETHLEHEM, Pa., Aug. 27 World-class care doesn,t have to be a world away. ... / NYW008LOGO ) , , That is the ... epherd Rehabilitation Network (GSRN) and B. Braun Medical ... innovative technology to enhance the delivery of rehabilitation services in the community. , ...
... , SEATTLE, Aug. 27 Dendreon Corporation (Nasdaq: ... on Thursday, September 24, 2009 beginning at 8:45 a.m. ET. , ... be accessible through the Investor Relations section of the Dendreon website, ... it will be archived on the site following the presentation. To access ...
Cached Biology Technology:Clinical Trials Offices Changing Academic Health Center Research Infrastructure 2Two Lehigh Valley Healthcare Leaders Collaborate to Deliver Safer, High-Quality Care to the Community 2Two Lehigh Valley Healthcare Leaders Collaborate to Deliver Safer, High-Quality Care to the Community 3Two Lehigh Valley Healthcare Leaders Collaborate to Deliver Safer, High-Quality Care to the Community 4
(Date:5/21/2013)... known for a long time that some creatures evolve ... particularly for plants. But it may be that height ... University and the U. S. National Evolutionary Synthesis Center. ... May in the journal Nature Communications , Lanfear ... , Drawing from a database of global patterns in ...
(Date:5/21/2013)... device attached to a whale entangled in fishing gear, ... changed a whale,s diving and swimming behavior. The monitoring ... and migrate, depletes their energy as they drag gear ... slow death. , The scientists in this entanglement response ... two-year-old female North Atlantic right whale called Eg 3911. ...
(Date:5/21/2013)... considered in the management of natural resources, and ... help them recognize and respond to the relationships ... , Place-Based Conservation: Perspectives from the Social ... Northwest Research Station,s Linda Kruger, can help managers ... is published by Springer Verlag and is available ...
Breaking Biology News(10 mins):Small but speedy: Short plants live in the evolutionary fast lane 2Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3
... from the Gulf of Mexico following the Deepwater Horizon oil ... (TIEHH) at Texas Tech University have reported that only 8 ... duck eggs resulted in a 50 percent mortality rate. ... remained at sea and exposed to weather had a significant ...
... a second look at your iced or steaming tea. ... school students using tabletop DNA technologies found several herbal ... unlisted on the manufacturers, package. The teen sleuths ... exported from India versus small-leaf teas exported from China. ...
... A red splash on a toxic butterfly,s wing screams DON,T ... wing pattern of another toxic species in the area. By ... US! , Now several research teams that include Smithsonian ... each other,s red wing patterns through changes in the same gene. ...
Cached Biology News:Deepwater Horizon crude less toxic to bird eggs after weathering at sea 2Unlisted ingredients in teas and herbal brews revealed in DNA tests by high school students 2Unlisted ingredients in teas and herbal brews revealed in DNA tests by high school students 3Unlisted ingredients in teas and herbal brews revealed in DNA tests by high school students 4Unlisted ingredients in teas and herbal brews revealed in DNA tests by high school students 5An eye gene colors butterfly wings red 2
Complement C1q subcomponent subunit C precursor. [Source:Uniprot/SWISSPROT;Acc:P02747] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Mouse monoclonal [CRC64] to Integrin alpha 2b + beta 3 ( Abpromise for all tested applications). Antigen: Human platelets Entrez Gene ID: 23295 Swiss Protein ID: P05106...
Rabbit polyclonal to NCoR2, prediluted ( Abpromise for all tested applications). entrezGeneID: 9612 SwissProtID: Q9Y618...
Goat polyclonal to Nebraska Calf Diarrhea Virus (FITC) ( Abpromise for all tested applications). Antigen: Bovine (Nebraska Calf Diarrhea Virus)....
Biology Products: